三博脑科医院管理集团股份有限公司

What 三博脑科医院管理集团股份有限公司 does

Sanbo Brain Hospital Management Group Co., Ltd. (三博脑科医院管理集团股份有限公司) is a publicly listed Chinese specialty neurological hospital chain (Shenzhen Stock Exchange code 301293, IPO May 2023) founded in 2003 by neurosurgery experts 栾国明, 于春江, 石祥恩, and healthcare management specialist 张阳. The group operates 9+ chain hospitals across 8 provinces with 2,400+ beds, including 6 Grade III neurospecialty hospitals, 1 Grade III comprehensive hospital, and 2 Grade II comprehensive hospitals, with the flagship Capital Medical University Sanbo Brain Hospital in Beijing designated as a National Clinical Key Specialty in Neurosurgery. The group employs 3,167 staff including 847 doctors (268 chief/deputy chief physicians) and serves more than 1.1 million outpatients, 70,000 inpatients, and performs 18,000+ surgeries annually. The group also maintains a National Drug and Medical Device Clinical Trial Institution and a National Neurosurgery Physician Training Base.

The core technology portfolio centers on specialized neurological and neurosurgical procedures including ROSA ONE robot-assisted surgery (0.3mm DBS precision), SEEG (stereotactic electroencephalography), cortical electrocoagulation for refractory epilepsy, multi-modal image fusion for stereotactic biopsy, and endovascular brain-computer interface technology (notably the world's first BCI human trial in June 2025). Revenue is generated primarily through fee-for-service medical care across outpatient consultations, inpatient treatment, surgeries, and diagnostic services, supplemented by clinical trial revenue, remote consultation services, and medical training programs. The group also operates a Medical Consortium network with over 100 partner hospitals for referrals and remote consultation.

The go-to-market model combines direct hospital services through the chain network with academic-hospital positioning anchored to Capital Medical University (11th Clinical Medical College), Tsinghua University BCI joint research, and partnerships with Nankai University, Beijing Institute of Technology, and Vietnam's Phenikaa Hospital. Marketing channels include official website, WeChat public account (sanbonaoke), academic conferences (Sanbo Neuroscience Forum), media coverage, and patient testimonials. The group is expanding geographically via new hospital construction (Hunan, 400 beds, RMB 700M investment) and acquisitions (Chengdu Sanbo Dongli Hospital). The customer base consists of individual patients with neurological conditions across China plus select international patients from Europe, America, and Southeast Asia, with medical consortium partner hospitals as a secondary B2B segment.

Name

三博脑科医院管理集团股份有限公司

Legal name

三博脑科医院管理集团股份有限公司

Website

https://sbnkjt.com

Company type

Public

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Sanbo Brain Hospital Management Group is a publicly listed Chinese specialty neurological hospital chain operating 9+ hospitals across 8 provinces with 2,400+ beds, serving 1.1M+ annual outpatients through advanced neurosurgery, epilepsy treatment, and brain-computer interface programs.

Ownership category

akta.pro rank

Product category

Neurological Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), General Medical and Surgical Hospitals (6221)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD)

akta.pro secondary industries

Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)

Keywords

• Neurological hospital services
• Neurosurgery specialty care
• Brain tumor treatment
• Epilepsy surgical services
• Chain hospital management

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Services Revenue: 三博脑科 generates revenue primarily through providing specialized neurological medical services including outpatient consultations, inpatient treatment, surgeries, and diagnostic services across its network of 9+ chain hospitals. The group operates as a healthcare service provider with fee-for-service model based on medical procedures and treatments rendered.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Sanbo Brain Hospital Management Group operates a chain network of 9+ specialized neurological hospitals across China, providing specialized neurological medical services including brain tumor surgery, epilepsy treatment, cerebrovascular disease treatment, spinal surgery, and functional neurosurgery. The group functions as a medical investment, hospital management, and brand operation company with an integrated 'medical, teaching, and research' model anchored by its flagship Capital Medical University Sanbo Brain Hospital.

Product overview

Sanbo Brain Hospital Management Group operates as a multi-hospital neurological specialty healthcare network. The group comprises 9 operating hospitals (6 neurological specialty Grade III hospitals, 1 Grade III comprehensive hospital, and 2 Grade II comprehensive hospitals), with 1 additional hospital under construction. The core portfolio includes the flagship Capital Medical University Sanbo Brain Hospital as the疑难病例诊疗中心 (difficult case diagnosis center), supplemented by satellite hospitals in Kunming, Chongqing (2), Fujian, Henan, Luoyang, Xi'an, and Chengdu. The group offers integrated services including remote consultation centers, pathology consultation centers, pain consultation centers, and epilepsy/glioma consultation centers. Service scope covers functional neurological diseases (epilepsy, Parkinson's, hemifacial spasm), brain tumors, cerebrovascular diseases, spinal/vertebral diseases, pediatric neurosurgery, and neurointervention. The group also operates education and training programs including neurosurgeon training bases and drug/medical device clinical trial institutions.

Differentiator

Problem solved

Functional benefit

Brands

• 三博集团远程医疗会诊中心: 远程医疗会诊服务
• 三博集团病理会诊中心
• 中国抗癫痫协会癫痫疑难症会诊中心
• 北京医师协会脑胶质瘤会诊中心
• 北京医师协会疑难疼痛会诊中心

Products and services

• Capital Medical University Sanbo Brain Hospital (首都医科大学三博脑科医院) Flagship hospital serving as the group's difficult case diagnosis center, talent training output center, and technology innovation center. National Clinical Key Specialty (Neurosurgery), National Drug/Device Clinical Trial Institution, with 480 beds.
• Kunming Sanbo Brain Hospital (昆明三博脑科医院) Yunnan Province Grade III neurological specialty hospital with 150 beds, offering neurology, neurosurgery, functional neurology, and surgery departments.
• Chongqing Sanbo Jiangling Hospital (重庆三博江陵医院) State-owned enterprise medical institution reform pilot project, Grade II comprehensive hospital with neurological specialty focus, offering medical, teaching, research, rehabilitation, and community health services.
• Chongqing Sanbo Chang'an Hospital (重庆三博长安医院) State-owned enterprise medical institution reform pilot project, Grade II comprehensive hospital with 'big specialty, strong comprehensive' development model, featuring 500+ beds and 480 staff members.
• Fujian Sanbo Brain Hospital (福建三博脑科医院) Fujian Province's first Grade III neurological specialty hospital, jointly established by Sanbo Group and Funeng Group, with 300 beds, implementing mixed-ownership reform under the '混合所有制模式'.
• Henan Sanbo Brain Hospital (河南三博脑科医院) Henan Province Grade III neurological specialty hospital operating under modular counterpart management with Capital Medical University Sanbo Brain Hospital, with 10 chief physicians and 20 deputy chief physicians.
• Luoyang 511 Sanbo Brain Hospital (洛阳伍一一三博脑科医院) Grade III specialty hospital with dual-core disciplines of brain science and obstetrics-gynecology-pediatrics, covering 40+ clinical departments including neurology, neurosurgery, gynecology, obstetrics, and pediatrics.
• Hunan Sanbo Brain Hospital (湖南三博脑科医院) Hospital under construction in Changsha, Hunan Province with 30,000 sqm land area, 70,000 sqm building area, 400 planned beds, and estimated 700 million RMB investment. Focus areas include pediatric neurology, neurology, neurosurgery, trauma/rehabilitation, tumor/spinal cord, functional/cerebrovascular, intervention, and brain health management.
• Xi'an Sanbo Brain Hospital (西安三博脑科医院) Grade III brain specialty hospital in Xi'an with 15,000 sqm total building area and 296 beds, focusing on neurosurgery, neurology, neurointervention, and neurorehabilitation through 'strong specialty, small comprehensive' model.
• Chengdu Sanbo Dongli Hospital (成都三博东篱医院)

Quantifiable outcome

• Epilepsy patients achieve 81.7% seizure-free rate with combined resection and cortical electrocoagulation treatment
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature7 records

Partnerships

13 partnerships are on record, tiered core and minor.

• 中国工程院外籍院士杜比教授团队coreStrategic or Co-development Partner · 1 June 2026三博脑科与中国工程院外籍院士杜比教授团队达成初步战略合作共识，拟共建中瑞神经科学研究院。
• 越南Phenikaa医院coreStrategic or Co-development Partner · 1 October 2025首都医科大学三博脑科医院与越南河内Phenikaa医院正式签署合作意向书，围绕神经外科领域人员交流、学术共建、远程医疗、临床研究四大关键维度，构建长期稳定的战略合作关系。
• 北京博润阳光科技有限公司coreStrategic or Co-development Partner · 1 July 2025首都医科大学三博脑科医院与北京博润阳光科技有限公司签署战略合作协议，加强创新药械研发高效合作，共同促进临床试验高质量发展。
• 浙江迈联医疗科技有限公司coreStrategic or Co-development Partner · 1 July 2025首都医科大学三博脑科医院与浙江迈联医疗科技有限公司在京召开调研座谈会，共话脑机接口领域产学研融合新机遇。
• 南开大学段峰教授团队coreStrategic or Co-development Partner · 1 June 2025三博脑科参与完成全球首例介入式脑机接口辅助人体患肢运动功能修复试验，由南开大学段峰教授团队牵头，联合完成介入式脑机接口技术实现人体运动功能修复。
• 李纤教授coreStrategic or Co-development Partner · 1 April 2025首都医科大学三博脑科医院举行校院双聘签约仪式，聘任李纤教授为首都医科大学第十一临床医学院副院长，加强科研团队建设。
• 北京理工大学minorStrategic or Co-development Partner · 1 January 2025集团与北京理工大学保持密切交流，积极拓展产学研合作机会，共同推动脑科学领域的基础研究与应用转化。
• 天大海河实验室minorStrategic or Co-development Partner · 1 January 2025集团与天大海河实验室保持密切交流，积极拓展产学研合作机会。
• 清华大学生物医学工程学院coreStrategic or Co-development Partner · 1 April 20242024年4月，首都医科大学三博脑科医院与清华大学生物医学工程学院联合成立了'脑机精准医学联合研究中心'，围绕医学科技创新、科研合作、人才培养等议题开展合作。
• 天使妈妈基金会 (Angel Mother Foundation)minorOthers · 1 December 2023三博脑科集团与天使妈妈基金会联合成立了脑病专项救助基金，用于救助家庭困难的脑病患者。2023年12月，该基金成功救助了一位患儿。
• 能化集团 (Fujian Funeng Group)coreStrategic or Co-development Partner三博脑科集团与福能集团（国资委旗下）共同出资设立福建三博脑科医院，是福建省首家三级神经专科医院，2017年7月开业，首开福建省大型国企引入社会办医的'混合所有制模式'先河。
• 首都医学科学创新中心coreStrategic or Co-development Partner首都医学科学创新中心梅林教授团队于2026年6月莅临首都医科大学三博脑科医院开展座谈交流，围绕医学科技创新、科研合作、人才培养等议题进行深入研讨。
• 首都医科大学公共卫生学院coreStrategic or Co-development Partner首都医科大学公共卫生学院师生赴三博脑科东坝院区观摩实践，加强院校与医院之间的沟通与合作，深入探讨护理实习生实习就业等相关合作。

Scale indicators15 records

Recent moves13 records

Expansion highlights8 records

Direct peers

• Aier Eye Hospital Group: China's largest listed specialty hospital chain (ophthalmology) on Shenzhen Stock Exchange; closest comparable in business model (chain specialty hospitals, listed, expansion-driven, referral-and-brand GTM). Differs only in clinical specialty.
• Phoenix Healthcare Group: Hong Kong-listed Chinese hospital group operating both general and specialty hospitals through a mix of M&A and reform partnerships (incl. SOE hospital reform); closely comparable mixed-ownership hospital chain model.
• Hygeia Healthcare Group: Hong Kong-listed oncology specialty hospital chain operating across China; highly comparable chain-specialty-hospital model with similar capital-markets access, tiered network of specialty centers, and physician-led GTM.
• Topchoice Medical Corporation: Shenzhen-listed medical aesthetics specialty hospital chain in China; another vertically-specialized Chinese chain-hospital model with similar multi-city roll-out, listed-company governance, and premium positioning.

Broad incumbents

• Universal Health Services: Large U.S.-listed for-profit hospital operator with a portfolio of acute care and behavioral health hospitals; comparable as a listed multi-site specialty/general hospital chain but operates in a very different regulatory and pricing environment.
• China Resources Medical Holdings: Large Hong Kong-listed Chinese state-owned hospital operator with a broad network of general and specialty hospitals; comparable as a scaled Chinese hospital operator but not specialty-neurosurgery focused.
• IHH Healthcare: Major pan-Asian publicly listed hospital operator (Malaysia/Turkey/Singapore); comparable as a scaled multi-country specialty/general hospital chain operator, though international rather than China-specific.

Emerging players

• Huaxia Eye Hospital Group: China-based ophthalmology specialty hospital chain (A-share listed or pre-listed); comparable as an emerging Chinese specialty chain pursuing similar expansion, though smaller and focused on a different specialty.

Regional players

• Bangkok Dusit Medical Services (BDMS): Largest private hospital group in Thailand and Southeast Asia, including premium neuroscience/neurosurgery centers (e.g., Bangkok Hospital); comparable as a regional premium specialty hospital chain but does not directly compete in China.

Others

• Meinian Onehealth Healthcare Group: China-listed preventive-health and体检 chain operating large-scale medical centers; adjacent peer as another Chinese listed healthcare-services platform, but focused on体检/preventive rather than inpatient specialty neurosurgery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E4%B8%89%E5%8D%9A%E8%84%91%E7%A7%91%E5%8C%BB%E9%99%A2%E7%AE%A1%E7%90%86%E9%9B%86%E5%9B%A2%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 三博脑科医院管理集团股份有限公司